Skip to content
DataLookout
Menu

Memorial Sloan Kettering Cancer Center clinical trial pipeline

Get alerts when Memorial Sloan Kettering Cancer Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

54 trials changed in the last 30 days: 2 stopped, 39 with notable changes, 13 with minor changes only.

  1. Stopped: Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study Trial status changed: Recruiting → Withdrawn Memorial Sloan Kettering Cancer CenterNot specified NCT07318402
  2. Notable: Ixazomib Maintenance Study · AL Amyloidosis Primary and study completion pushed from Aug 2026 to Aug 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT03618537
  3. Notable: Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes · Non-Metastatic Breast Cancer Primary and study completion pushed from Aug 2026 to Aug 2027 Memorial Sloan Kettering Cancer CenterNot specified NCT02530177
  4. Minor: In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET Enrollment closed, study ongoing Memorial Sloan Kettering Cancer CenterEarly Phase 1 NCT05093335
  5. Minor: Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer Trial completed Memorial Sloan Kettering Cancer CenterNot applicable NCT04435444
  6. Notable: Radiation Therapy and Cemiplimab · Skin Cancer Primary and study completion pushed from Oct 6, 2026 to Oct 6, 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT05574101
  7. Notable: Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) Primary and study completion dates moved earlier to Jul 31, 2029 Memorial Sloan Kettering Cancer CenterNot applicable NCT07144800
  8. Notable: Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT04148430
  9. Notable: Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes · Vulvar Cancer Primary and study completion pushed from Nov 2026 to Nov 2027 Memorial Sloan Kettering Cancer CenterNot applicable NCT06127836
  10. Notable: Neurocognitive Tests and Questionnaires · Head and Neck Cancer Who Are Undergoing Radiation Therapy Enrollment increased: 60 → 185 participants Memorial Sloan Kettering Cancer CenterNot specified NCT05207098
  11. Minor: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients Enrollment closed, study ongoing Memorial Sloan Kettering Cancer CenterPhase 2 NCT03587844
  12. Minor: Iomab-ACT · 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy · Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma Enrollment closed, study ongoing Memorial Sloan Kettering Cancer CenterEarly Phase 1 NCT04512716
  13. Notable: Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation · Multiple Myeloma and AL Amyloidosis Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT03315026
  14. Notable: Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT02269150
  15. Notable: Proton Versus Photon Beam Radiotherapy · Head and Neck Cancer Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 2 NCT02923570
  16. Notable: Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 1 NCT02278744
  17. Notable: Radiation Therapy Before CAR T Cell Therapy · B Cell Lymphoma Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 1 NCT05574114
  18. Notable: Genomic Structural Variation in Cancer Susceptibility Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterNot specified NCT00996710
  19. Minor: Ruxolitinib and Duvelisib · Lymphoma Enrollment closed, study ongoing Memorial Sloan Kettering Cancer CenterPhase 1 NCT05010005
  20. Notable: Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy Primary and study completion pushed from Oct 2026 to Oct 2027 Memorial Sloan Kettering Cancer CenterPhase 3 NCT01223248
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-10 NCT07927998 A Study of Retifanlimab After Chemoradiation in People With Anal Cancer Phase 2 Recruiting
2026-11-05 NCT07918989 A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast… Phase 2 Recruiting
2026-11-03 NCT07913672 A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD) Phase 1 Recruiting
2026-10-28 NCT07899892 A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer Phase 1 Recruiting
2026-10-27 NCT07898111 A Study of VAX-ID® 2200, a New Device for Intradermal Injections Enrolling by Invitation
2026-10-26 NCT07895498 A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced… Phase 2 Recruiting
2026-10-26 NCT07895511 A Study of Skipping Radiation Therapy in People With Breast Cancer Recruiting
2026-10-22 NCT07890415 Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis Phase 3 Recruiting
2026-10-21 NCT07886801 A Study of Ropeg-Interferon in People With Polycythemia Vera Phase 2 Recruiting

Active trials by phase

Early Phase 1
20
Phase 1
93
Phase 1/2
39
Phase 2
236
Phase 2/3
1
Phase 3
23
Phase 4
6
Not charted: 289 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 48

Get alerts when Memorial Sloan Kettering Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free